Brind.

Biodesix, a COE for NGS Diagnostics, provided data to Thermo Fisher Scientific for an FDA regulatory submission.

2 reports, 1 independent Updated Aug 19
Gone quiet
Reports
2
Developments
2
Repetition
0%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Biodesix, a COE for NGS Diagnostics, provided data to Thermo Fisher Scientific for an FDA regulatory submission.

Who's involved

What this event is mainly about
Thermo Fisher Scientific (Netherlands)FDA

How it developed

Newest first. Tap a step to see who reported it.
  1. Biodesix partnered with Thermo Fisher to submit NGS diagnostic data to the FDA.1 source
  2. FDA approved a diagnostic tool and new strategic collaborations involving Thermo Fisher Scientific.

Keep exploring

The entities involved

Related events

Coverage

Newest first; wire copies grouped
  • GlobeNewswireBiodesix Recognized as a Thermo Fisher Scientific Center of Excellence (COE) for NGS Diagnostics Biodesix recently validated Thermo Fisher’s tissue-based Oncomine Dx Express Test for solid tumors on
  • Unknown outlet